InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Charles W. Newton
18 Aug 2026
Director
Sold on a plan
551
$10.30
$5.68K
Esther Cho
18 Aug 2026
Chief Legal Officer
Sell
4,485
$10.29
$46.15K
Lorena Raquel Lerner
18 Aug 2026
Chief Scientific Officer
Sell
3,568
$10.29
$36.71K
Annita Tanini
18 Aug 2026
Corp. Controller & VP, Finance
Sell
1,224
$10.29
$12.59K
Jean Jacques Bienaime
17 Aug 2026
Director
Buy
1,000
$10.27
$10.27K
Jean Jacques Bienaime
15 Jul 2026
Director
Buy
1,000
$10.61
$10.61K
Jean Jacques Bienaime
15 Jun 2026
Director
Buy
1,000
$10.19
$10.19K
Charles W. Newton
11 Jun 2026
Director
Sold on a plan
550
$10.04
$5.52K
Alpna Seth
4 Jun 2026
Director
Sold on a plan
2,625
$10.72
$28.14K
Julius Knowles
4 Jun 2026
Director
Sold on a plan
2,625
$10.73
$28.17K
Nima Farzan
4 Jun 2026
Director
Sold on a plan
2,625
$10.73
$28.17K
Jean Jacques Bienaime
15 May 2026
Director
Buy
1,000
$10.58
$10.58K
Jean Jacques Bienaime
15 Apr 2026
Director
Buy
1,000
$11.70
$11.70K
Jasbir Seehra
2 Apr 2026
Chief Executive Officer
Exercised, kept
55,000
$0.30
$16.50K
Jean Jacques Bienaime
9 Mar 2026
Director
Buy
2,000
$11.21
$22.42K
Jasbir Seehra
19 Feb 2026
Chief Executive Officer
Sell
7,015
$16.17
$113.43K
Keith Regnante
18 Feb 2026
Chief Financial Officer
Sell
4,739
$16.35
$77.48K
Esther Cho
18 Feb 2026
SVP, General Counsel
Sell
4,745
$16.35
$77.58K
Lorena Raquel Lerner
18 Feb 2026
Chief Science Officer
Sell
3,873
$16.35
$63.32K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 868,776
History held since 8 Apr 2020